
Marksans Pharma Limited has informed the Exchange regarding a press release dated October 03, 2023, titled " US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC)".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated October 03, 2023, titled " US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC)".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma